News

Excellent research article award to Mehrdad Rakaee

Congratulations!

Mehrdad Rakaee was awarded Oslo University Hospital’s prize for excellent research article 2nd semester 2024 for the paper:

Mehrdad Rakaee, Masoud Tafavvoghi, Biagio Ricciuti, Joao V. Alessi, Alessio Cortellini, Fabrizio Citarella, Lorenzo Nibid, Giuseppe Perrone, Elio Adib, Claudia A. M. Fulgenzi, Cassio Murilo Hidalgo Filho, Alessandro Di Federico, Falah Jabar, Sayed Hashemi, Ilias Houda, Elin Richardsen, Lill-Tove Rasmussen Busund, Tom Donnem, Idris Bahce, David J. Pinato, Åslaug Helland, Lynette M. Sholl, Mark M. Awad og David J. Kwiatkowski:
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer
JAMA Oncology; 2025; 11(2):109-118; epub: 26. desember 2024: doi.org/10.1001/jamaoncol.2024.5356

He received the prize on the 27th of May 2025 together with the five other winners.

News article from ous-research.no:
Oslo University Hospital has awarded 6 excellent articles for the second half-year of 2024

 

ASCO 2025

ASCO has released the abstracts for the annual meeting 2025. We are first/last authors for several abstracts: 

 

13.05.2025 Scientific seminar and teambuilding

Espen Haavardsholm, Centre Leader of REMEDY, Diakonhjemmet Hospital

We started scientifically:

  • Espen Haavardsholm from Diakonhjemmet, centre leader of REMEDY, presented all the activities and projects of this research centre for rheumatological and musculoskeletal diseases.
  • Kushtrim Kryeziu from Department of Molecular Oncology had a very interesting talk about the establishment of their impressive biobank of patient-derived tumour organoids and gave some tips on how to work with organoid models.

Then we turned to artistic and creative activities at Paint On Pots before we ended the day with dinner on Aker brygge. In conclusion a very interesting, inspiring and social day.

 

Strategy meeting – 28.05.2024

Just prior to starting the summer season, the senior members of group for Translational studies on solid tumours met up to share results so far in 2024 and to discuss plans and future projects. With a number of funding applications in preparation to the Norwegian Cancer Society, the Norwegian research Council and the South-Eastern Norway Regional Health Authority, as well as several manuscripts in preparation, there should be enough exciting work to keep us all busy and happy over summer and into the autumn season.

Present from left to right: Elisabeth Müller (researcher), Vilde Drageset Haakensen (project group leader), Åslaug Helland (group leader), Mehrdad Rakaee (senior researcher), Åsa Kristina Øjlert (postdoc), Tine Norman Alver (postdoc) and Anna Christina Garvert (postdoc).